SEARCH

SEARCH BY CITATION

References

  • AHMAD, S., FOWLER, L.J., LEACH, M.J. & WHITTON, P.S. (1995). Lamotrigine alters veratridine but not high K+ evoked amino acid release in the ventral hippocampus of the rat in vivo. Br. Pharmacol. Soc., 115, 116P.
  • BAZIL, C.W. (2002). New antiepileptic drugs. Neurology, 8, 7181.
  • BEQUET, D., FOUDON, M. & HERY, F. (1990). In vivo evidence for an inhibitory glutamatergic control of serotonin release in the cat caudate nucleus: involvement of GABA neurons. Brain Res., 519, 8288.
  • BIGGS, C.S., PEARCE B.R. FOWLER, L.J. & WHITTON, P.S. (1992). Regional effects of sodium valproate on extracellular concentrations of 5-hydroxytryptamine, dopamine and their metabolites in rat brain: an in vivo microdialysis study. J. Neurochem., 59, 17021708.
  • BOWDEN, C.L., CALABRESE, J.R., SACHS, G., YATHAM, L.N., ASGHAR, S.A., HOMPLAND, M., MONTGOMERY, P., EARL, N., SMOOT, T.M. & DEVEUGH-GRIESS, P. (2003). A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch. Gen. Psychiatry, 60, 392400.
  • BTAICHE, I.F. & WOSTER, P.S. (1995). Gabapentine and lamotrigine: novel antiepileptic drugs. Am. J. Health Syst. Pharm., 52, 6169.
  • CALABRESE, J.R., SHELTON, M.D., RAPPORT, D.J., KIMMEL, S.E. & ELHAJ, O. (2002). Long-term treatment of bipolar disorder with lamotrigine. J. Clin. Psychiatry, 10 (Suppl), 1822.
  • DERANSART, C. & DEPAULIS, A. (2002). The control of seizures by the basal ganglia — a review of the experimental data. Epileptic Disord, 4 (Suppl 3), S61S72.
  • DURSUN, S.M. & DEAKIN, J.F. (2001). Augmenting antipsychotic treatment with lamotrigine or topiramate in patients with treatment-resistant schizophrenia: a naturalistic case-series outcome study. J. Psychopharmacol, 15, 297301.
  • GOLDSMITH, D., WAGSTAFF, A., IBBOTSON, T. & PERRY, C. (2003). Lamotrigine: a review of its use in bipolar disorder. Drugs, 63, 20292050.
  • HADDJERI, N., SZABO, S.T., DE MONTIGNY, C. & BLIER, P. (2000). Increased tonic activation of rat forebrain 5-HT(1A) receptors by lithium addition to antidepressant treatments. Neuropsychopharmacolology., 22, 346356.
  • ICHIKAWA, J. & MELTZER, H.Y. (1999). Valproate and carbamazepine increase prefrontal dopamine release by 5-HT1A receptor activation. Eur. J. Pharmacol., 380, R1R3.
  • JOVIC, N.J., MIRKOVIC, D., MAJKIC-SINGH, N. & MILOVANOVIC, D.D. (1999). Plasma and urinary serotonin and 5-HIAA in children treated with lamotrigine for intractable epilepsy. Adv. Exp. Med. Biol., 467, 297302.
  • KAUR, S. & STARR, M.S. (1996). Motor effects of lamotrigine in naive and dopamine-depleted mice. Eur. J. Pharmacol., 304, 16.
  • LEES, G. & LEACH, M.J. (1993). Studies on the mechanism of action of the novel anticonvulsant lamotrigine (Lamactil) using primary neurological cultures from rat cortex. Brain Res., 612, 190199.
  • LOPEZ-IBOR, J.J. (1992). Serotonin and psychiatric disorders. Int. Clin. Psychopharm., 7 (Suppl), 511.
  • LOSCHER, W., ANNIES, R. & HONACK, D. (1991). The N-methyl-D-aspartate receptor antagonist MK-801 induces increases in serotonin and dopamine metabolism in several brain regions of rats. Neurosci. Lett., 128, 191194.
  • LOSCHMANN, P.A., EBLEN, F., WULLNER, U., WACHTEL, H. & KOCKGETHER, T. (1995). Lamotrigine has no antiparkinsonian activity in rat models of Parkinson's disease. Eur. J. Pharmacol., 284, 129134.
  • MAHLI, G.S., MITCHELL, P.B. & SALIM, S. (2003). Bipolar depression: management options. CNS Drugs, 17, 925.
  • MAIONE, S., ROSSI, F., BIGGS, C.S., FOWLER, L.J. & WHITTON, P.S. (1997). AMPA receptors modulate extracellular 5-hydroxytryptamine concentration and metabolism in rat striatum in vivo. Neurochem. Int., 30, 299304.
  • OKADA, M., HIRANO, T., MIZUNO, K., CHIBA, T., KAWATA, Y., KIRYU, K., WADA, K., TASAKI, H. & KANEKO, S. (1997). Biphasic effects of carbamazepine on the dopaminergic system in rat striatum and hippocampus. Epilepsy Res., 28, 143153.
  • OKADA, M., HIRANO, T., MIZUNO, K., KAWATA, T., WADA, K., MURAKAMI, T., TASAKI, H. & KANEKO, S. (1998). Effects of carbamazepine on hippocampal serotonergic system. Epilepsy Res., 31, 187198.
  • PAXINOS, G. & WATSON, C. (1982). The Rat Brain In Stereotaxic Coordinates. New York: Academic Press.
  • PHILLIPS, M.L., DREVETS, W.C., RAUCH, S.L. & LANE, R. (2003). Neurobiology of emotion perception II: implications for major psychiatric disorders. Biol. Psychiatry, 54, 515528.
  • REMY, S., URBAN, B.W., ELGER, C.E. & BECK, H. (2003). Anticonvulsant pharmacology of voltage-gated Na+ channels in hippocampal neurons of control and chronically epileptic rats. Eur. J. Neurosci., 17, 26482658.
  • SHIAH, I.S., YATHAM, L.N., LAM, R.W. & ZIS, A.P. (1998). Effects of lamotrigine on the 5-HT1A receptor function in healthy human males. J. Affect. Disord., 49, 157162.
  • SOUTHAM, E., KIRBY, D., HIGGINS, G.A. & HAGAN, R.M. (1998). Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in rats. Eur. J. Pharmacol., 358, 1924.
  • TOCZEK, M.T., CARSON, R.E., LANG, L., MA, Y., SPANAKI, M.V., DER, M.G., FAZILAT, S., KOPYLEV, L., HERSCOVITCH, P., ECKLEMAN, W.C. & THEODORE, W.H. (2003). PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy. Neurology, 60, 749756.
  • VINOD, K.Y. & SUBHASH, M.N. (2002). Lamotrigine induced selective changes in 5-HT(1A) receptor mediated response in rat brain. Neurochem. Int., 40, 315319.
  • VRIEND, J. & ALEXIUK, N.A. (1997). Lamotrigine inhibits the in situ activity of tyrosine hydroxylase in striatum of audiogenic seizure prone and audiogenic seizure resistant Balb/c mice. Life Sci., 61, 24672474.
  • WHITTON, P.S., BIGGS, C.S., PEARCE, B.R. & FOWLER, L.J. (1992). MK-801 increases extracellular 5-hydroxytryptamine in rat hippocampus and striatum in vivo. J. Neurochem., 58, 15731575.
  • WHITTON, P.S. & FOWLER, L.J. (1991). The effect of valproic acid on 5-hydroxytryptamine and 5-hydroxyindoleacetic acid concentration in hippocampal dialysates in vivo. Eur. J. Pharmacol, 200, 167169.
  • WHITTON, P.S., RICHARDS, D.A., BIGGS, C.S. & FOWLER, L.J. (1994a). N-methyl-D-aspartate receptors modulate extracellular 5-hydroxytryptamine concentration in rat hippocampus and striatum in vivo. Neurosci. Lett., 169, 215218.
  • WHITTON, P.S., MAIONE, S., BIGGS, C.S. & FOWLER, L.J. (1994b). N-methyl-D-aspartate receptors modulate extracellular dopamine concentration and metabolism in rat hippocampus and striatum. Brain Res., 635, 312316.
  • XIE, X., DALE, T.J., JOHN, V.H., CATER, H.L., PEAKMAN, T.C. & CLARE, J.J. (2001). Electrophysiological and pharmacological properties of the human brain type IIA Na+ channel expressed in a stable mammalian cell line. Pflugers Arch., 441, 425433.